Asia Pacific Anterior Uveitis Treatment Market Size & Outlook
Asia Pacific anterior uveitis treatment market, 2018-2030 (US$M)
Related Markets
Asia Pacific anterior uveitis treatment market highlights
- The Asia Pacific anterior uveitis treatment market generated a revenue of USD 79.9 million in 2022.
- The market is expected to grow at a CAGR of 7.8% from 2023 to 2030.
- In terms of segment, non-infectious uveitis was the largest revenue generating type in 2022.
- Non-Infectious Uveitis is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 79.9 million |
| Market revenue in 2030 | USD 146.2 million |
| Growth rate | 7.8% (CAGR from 2022 to 2030) |
| Largest segment | Non-infectious uveitis |
| Fastest growing segment | Non-Infectious Uveitis |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Uveitis, Non-Infectious Uveitis |
| Key market players worldwide | Novartis AG ADR, Santen Pharmaceutical Co Ltd, AbbVie Inc, Kiora Pharmaceuticals Inc, Clearside Biomedical Inc, Aldeyra Therapeutics Inc, UCB SA, Aciont, Sirion Therapeutics, Lux Biosciences |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.9% of the global anterior uveitis treatment market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 485.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anterior Uveitis Treatment Market Scope
Anterior Uveitis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific anterior uveitis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anterior uveitis treatment market will help companies and investors design strategic landscapes.
Non-infectious uveitis was the largest segment with a revenue share of 54.19% in 2022. Horizon Databook has segmented the Asia Pacific anterior uveitis treatment market based on infectious uveitis, non-infectious uveitis covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Asia Pacific anterior uveitis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific anterior uveitis treatment market databook
-
Our clientele includes a mix of anterior uveitis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific anterior uveitis treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific anterior uveitis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific anterior uveitis treatment market size, by country, 2018-2030 (US$M)
Asia Pacific Anterior Uveitis Treatment Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
